Subscribe To
Cps to host conference call on first quarter 2022 earnings
Las Vegas, Nevada, April 15, 2022 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announce...
April 15, 2022, 5:09 pm
Gracell biotechnologies to present data at aacr annual meeting 2022 showcasing early first-in-human results for gc502 in r/r b-all
Allogeneic, off-the-shelf CAR-T therapy with CD19/CD7 dual-directed CAR shows promising early results in patients with r/r B-ALL PALO ALTO, Calif. and...
April 8, 2022, 4:00 pm
Dow jones newswires: u.s proxy adviser iss recommends toshiba shareholders vote against split plan
U.S proxy advisory firm Institutional Shareholder Services has recommended that Toshiba Corp.'s 6502, +...
March 9, 2022, 10:38 pm
Dow jones newswires: toshiba ceo satoshi tsunakawa resigns amid restructuring turmoil
Toshiba Corp. 6502, +4.98% said Tuesday that Satoshi Tsunakawa had stepped down as chief executive amid...
February 28, 2022, 10:07 pm
Dow jones newswires: toshiba ceo satoshi tsunakawa resigns amid restructuring turmoil
Toshiba Corp. 6502, +4.98% said Tuesday that Satoshi Tsunakawa had stepped down as chief executive amid...
February 28, 2022, 10:07 pm
Dow jones newswires: toshiba ceo satoshi tsunakawa resigns amid restructuring turmoil
Toshiba Corp. 6502, +4.98% said Tuesday that Satoshi Tsunakawa had stepped down as chief executive amid...
February 28, 2022, 10:07 pm
Cps to host conference call on fourth quarter 2021 earnings
LAS VEGAS, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that it...
February 10, 2022, 1:29 pm
Cps to host conference call on fourth quarter 2021 earnings
LAS VEGAS, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that it...
February 10, 2022, 1:29 pm
Cps to host conference call on fourth quarter 2021 earnings
LAS VEGAS, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that it...
February 10, 2022, 1:29 pm
Housing construction performed well in november
Total housing starts rose to a 1.679 million annual rate in November from a 1.502 million pace in Octob...
December 17, 2021, 1:12 pm
Housing construction performed well in november
Total housing starts rose to a 1.679 million annual rate in November from a 1.502 million pace in Octob...
December 17, 2021, 1:12 pm
Housing construction performed well in november
Total housing starts rose to a 1.679 million annual rate in November from a 1.502 million pace in Octob...
December 17, 2021, 1:12 pm
Fda advisory committee recommends use of investigational drug maribavir (tak-620) to treat post-transplant recipients with cytomegalovirus (cmv) infection and disease refractory to treatment with or w
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:...
October 7, 2021, 6:15 pm
Fda advisory committee recommends use of investigational drug maribavir (tak-620) to treat post-transplant recipients with cytomegalovirus (cmv) infection and disease refractory to treatment with or w
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:...
October 7, 2021, 6:15 pm
Fda advisory committee recommends use of investigational drug maribavir (tak-620) to treat post-transplant recipients with cytomegalovirus (cmv) infection and disease refractory to treatment with or w
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:...
October 7, 2021, 6:15 pm
Fda advisory committee recommends use of investigational drug maribavir (tak-620) to treat post-transplant recipients with cytomegalovirus (cmv) infection and disease refractory to treatment with or w
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:...
October 7, 2021, 6:15 pm
Fda advisory committee recommends use of investigational drug maribavir (tak-620) to treat post-transplant recipients with cytomegalovirus (cmv) infection and disease refractory to treatment with or w
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:...
October 7, 2021, 6:15 pm
Fda advisory committee recommends use of investigational drug maribavir (tak-620) to treat post-transplant recipients with cytomegalovirus (cmv) infection and disease refractory to treatment with or w
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:...
October 7, 2021, 6:15 pm
Takeda provides update on tak-994 clinical program
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:...
October 5, 2021, 7:33 pm
Takeda provides update on tak-994 clinical program
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:...
October 5, 2021, 7:33 pm